BNTX

BioNTech SE ADR

Feb 02 • 04:00PM ET

108.88

-4.87 -4.28 %

Healthcare • Biotechnology • Germany • NASD

Feb 02, 10:00 AMLeerink downgraded BioNTech (BNTX) to Market Perform from Outperform and raised its price target to $113, citing a lack of meaningful confirming data readouts until 2027 or later.

Peers: MRNA PFE NVAX AZN-D JNJ GSK BMY GILD LLY SNY

| Held by: FBT IBB FNDF TCAF SPDW BBH BBEU IDNA QQQJ KOMP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.63	Insider Own	0.69%	Shs Outstand	240.46M	Perf Week	-7.73%
Market Cap	26.18B	Forward P/E	-	EPS next Y	-2.74	Insider Trans	0.00%	Shs Float	238.79M	Perf Month	14.37%
Enterprise Value	9.58B	PEG	-	EPS next Q	-0.20	Inst Own	18.63%	Short Float	2.03%	Perf Quarter	4.02%
Income	-632.54M	P/S	7.41	EPS this Y	-21.90%	Inst Trans	-6.30%	Short Ratio	4.11	Perf Half Y	1.43%
Sales	3.53B	P/B	1.21	EPS next Y	31.23%	ROA	-2.53%	Short Interest	4.84M	Perf YTD	14.37%
Book/sh	90.29	P/C	1.55	EPS next 5Y	-5.59%	ROE	-2.94%	52W High	124.98 -12.88%	Perf Year	-9.93%
Cash/sh	70.26	P/FCF	-	EPS past 3/5Y	- -25.87%	ROIC	-2.88%	52W Low	81.20 34.09%	Perf 3Y	-23.61%
Dividend Est.	-	EV/EBITDA	50.81	Sales past 3/5Y	-49.00% 89.57%	Gross Margin	82.79%	Volatility	2.34% 3.13%	Perf 5Y	3.81%
Dividend TTM	-	EV/Sales	2.71	EPS Y/Y TTM	-25.13%	Oper. Margin	-6.68%	ATR (14)	3.69	Perf 10Y	-
Dividend Ex-Date	Jun 02, 2022	Quick Ratio	7.02	Sales Y/Y TTM	7.05%	Profit Margin	-17.91%	RSI (14)	51.57	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	7.12	EPS Q/Q	-115.68%	SMA20	-0.03%	Beta	1.51	Target Price	144.05
Payout	-	Debt/Eq	0.01	Sales Q/Q	29.80%	SMA50	7.67%	Rel Volume	0.91	Prev Close	113.75
Employees	6772	LT Debt/Eq	0.01	Earnings	Nov 03 BMO	SMA200	4.66%	Avg Volume	1.18M	Price	108.88
IPO	Oct 10, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	87.51% 108.91%	Trades		Volume	1,063,944	Change	-4.28%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-02-26	Downgrade	Leerink Partners	Outperform → Market Perform	$113
Jan-16-26	Upgrade	Goldman	Neutral → Buy	$142
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99

Show Previous Ratings

Feb-02-26 09:47AM	Palantir upgraded, Best Buy downgraded: Wall Street's top analyst calls (The Fly)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
Jan-31-26 06:09AM	Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum (TipRanks)
Jan-30-26 08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:58AM	Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? (Zacks)
02:07AM	Loading…
02:07AM	Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline (Insider Monkey)
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire)
09:13AM	BioNTech SE (BNTX): A Bull Case Theory (Insider Monkey)
08:00AM	BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer (GlobeNewswire)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
05:38AM	Pfizers CEO on leading after a moonshotand making deals with Trump (Fortune)
05:32AM	What Are Wall Street Analysts' Target Price for Pfizer Stock? (Barchart)
Jan-22-26 10:28AM	BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? (Zacks)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-20-26 01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
09:01AM	Loading…
Jan-19-26 09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-16-26 09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
Jan-14-26 07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-12-26 06:45AM	BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
Dec-23-25 12:53AM	BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. (Insider Monkey)
Dec-18-25 04:45AM	BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field (GlobeNewswire)
Dec-15-25 09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
07:44AM	BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street (Insider Monkey)
Dec-09-25 07:00AM	BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer (GlobeNewswire)
Dec-06-25 03:30PM	BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-03-25 09:01AM	BioNTech Achieves Minimum Condition in CureVac Exchange Offer (GlobeNewswire)
Dec-02-25 09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
04:41PM	Loading…
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.58%
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
12:24PM	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 (Yahoo Finance Video)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)
11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
09:36AM	Moderna Falls as FDA Vows to Impose New Vaccine Requirements (Bloomberg)
Nov-26-25 07:30AM	BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration (GlobeNewswire)
Nov-19-25 09:42PM	Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? (Barchart)
Nov-17-25 08:58AM	BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ (Zacks)
Nov-14-25 06:41AM	Pfizer Cuts BioNTech Stake by More Than Half (GuruFocus.com)
Nov-13-25 01:24PM	Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up (GuruFocus.com) -7.00%
06:23AM	CPHI 2025: handprint metric bridges pharma sustainability and economic value (Pharmaceutical Technology)
Nov-05-25 11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-03-25 02:01PM	BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments (GuruFocus.com)
07:13AM	BioNTech Boosts FY25 Revenue Outlook - Update (RTT News)
06:45AM	BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update (GlobeNewswire)
Oct-30-25 10:32AM	BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View (Zacks)
09:56AM	Singapore Approves Latest Pfizer/BioNTech COVID-19 Vaccine for All Ages (Insider Monkey)
Oct-28-25 01:25PM	3 Stocks Under $30: Where to Put $1,000 to Work Today (24/7 Wall St.)
07:45AM	BioNTech to Host Innovation Series R&D Day on November 11, 2025 (GlobeNewswire)
Oct-27-25 09:17AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? (Zacks)
07:45AM	BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 (GlobeNewswire)
Oct-22-25 06:45AM	BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. (GlobeNewswire)
Oct-20-25 10:15AM	Pfizer's Q3 Non-Oncology Performance: Here's What to Expect (Zacks)
Oct-17-25 08:40AM	Euronext backs German push for single European stock exchange (Euronews)
Oct-14-25 05:27PM	R&D spending now can have big payoffs later for companies (TheStreet)
10:01AM	BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? (Zacks)
Oct-08-25 10:15AM	Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead (Motley Fool)
Oct-02-25 10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
Oct-01-25 06:13PM	Why BioNTech Stock Jumped by Nearly 4% on Wednesday (Motley Fool)
Sep-24-25 09:43AM	BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study (Zacks)
Sep-23-25 06:45AM	BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 (GlobeNewswire)
Sep-22-25 06:45PM	Why BioNTech Stock Bumped Higher Today (Motley Fool)
09:54AM	Analyst Report: BioNTech SE (Morningstar Research)
Sep-19-25 04:24PM	CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids (Investor's Business Daily)
Sep-18-25 01:53PM	The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut (Investor's Business Daily)
08:45AM	Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises (PR Newswire)
Sep-17-25 10:04AM	MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response (Zacks)
Sep-15-25 08:56AM	COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths (Zacks)
04:00AM	Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? (Pharma Voice)
Sep-14-25 01:16AM	BMO Capital Maintains a Buy on BioNTech SE (BNTX) (Insider Monkey)
Sep-13-25 01:56PM	Moderna shares hit a low after report suggests the FDA plans to tie COVID shots to child deaths (FastCompany)
Sep-12-25 07:43PM	Drugmakers Fall on Report US to Claim Covid Shot Killed Kids (Bloomberg) -7.26%
06:19PM	Why BioNTech Stock Sank by More Than 7% Today (Motley Fool)
04:21PM	Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
02:11PM	Vaccine Stocks Down Following Report of Plans to Link Covid Shot With Child Deaths (The Wall Street Journal)
01:37PM	COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says (MarketWatch)
12:33PM	Pfizer, Moderna, BioNTech trade lower amid report of vaccine link to child deaths (Investing.com)
12:11PM	Trump officials to link child deaths to COVID shots, Washington Post reports (Reuters)
11:35AM	Stock Market Today: Investors await opening trade from Gemini, Via, and Legence (TheStreet)
09:08AM	BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? (Zacks)
Sep-11-25 01:01PM	Bristol Myers Squibb, BioNTech Announce Positive Interim Data from Phase 2 Trial of Pumitamig in Lung Cancer (Insider Monkey)
09:52AM	Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? (Zacks)
Sep-09-25 01:17PM	SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study (Zacks)
Sep-08-25 06:12PM	Today's Moving Stocks: Planet Labs, EchoStar, Robinhood, Summit Therapeutics, BioNTech, CVS Health (TheStreet) -8.71%
04:08PM	Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch (Investor's Business Daily)
01:41PM	Amid Vaccine Controversy, Pfizer Says New Covid Shots Are Effective (Barrons.com)
11:26AM	Stock Market Today: Stocks rise as investors embrace supersized cut chances (TheStreet)
11:00AM	First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity (GlobeNewswire)
06:45AM	Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula (Business Wire)
Sep-05-25 04:41PM	Why BioNTech Stock Crushed the Market Today (Motley Fool) +8.66%
01:46PM	BioNTech and Dualitys ADC trumps Kadcyla, but analysts unimpressed (Clinical Trials Arena)
12:22PM	Analyst Report: BioNTech SE (Morningstar Research)
10:27AM	Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? (Investor's Business Daily)
09:27AM	BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb (Investor's Business Daily)
09:09AM	BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data (Benzinga)
Aug-31-25 08:40AM	Large-cap biotech is a sector to watch for investors: Analysts (Yahoo Finance)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Tureci Ozlem	Officer	Nov 28 '25	Proposed Sale	102.70	123,331	12,666,094	Nov 28 07:10 AM
Medine GmbH	Officer	Nov 13 '25	Proposed Sale	111.70	1,114,130	124,448,321	Nov 13 08:23 AM
Jeggle Helmut Wolfgang	Director	Nov 05 '25	Proposed Sale	103.43	150,000	15,514,500	Nov 05 04:52 PM
ATHOS KG	10% Owner	Sep 05 '25	Proposed Sale	112.46	500,000	56,230,000	Sep 05 04:41 PM
Medine GmbH	Officer	Aug 15 '25	Proposed Sale	112.70	1,774,837	200,024,130	Aug 15 08:27 AM
Tureci Ozlem	Officer	Aug 15 '25	Proposed Sale	112.70	185,001	20,849,613	Aug 15 08:22 AM
Jeggle Helmut Wolfgang	Director	Jun 04 '25	Proposed Sale	113.10	150,000	16,965,000	Jun 04 08:31 AM
ATHOS KG	10% Owner	Jun 02 '25	Proposed Sale	110.83	175,000	19,394,800	Jun 02 04:08 PM
ATHOS KG	10% Owner	May 28 '25	Proposed Sale	98.68	500,000	49,340,000	May 28 09:00 AM
Jeggle Helmut Wolfgang	Director	May 07 '25	Proposed Sale	94.74	150,000	14,211,000	May 07 07:30 AM
Richardson Ryan	Officer	Feb 27 '25	Proposed Sale	114.00	26,500	3,021,000	Feb 27 07:57 AM
Medine GmbH	Officer	Feb 20 '25	Proposed Sale	119.58	1,000,000	119,580,000	Feb 20 07:53 AM
Poetting Sierk	Officer	Feb 20 '25	Proposed Sale	119.58	120,000	14,349,600	Feb 20 07:50 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience